Late-breaking TAILORx data to be presented at ESMO Congress 2019

New data from TAILORx, the federally funded, phase three clinical trial, will be presented as late-breaking information at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain.

From http://besthealthnews.com/2019/09/late-breaking-tailorx-data-to-be-presented-at-esmo-congress-2019/?utm_source=rss&utm_medium=rss&utm_campaign=late-breaking-tailorx-data-to-be-presented-at-esmo-congress-2019

from
https://healthnews010.wordpress.com/2019/09/26/late-breaking-tailorx-data-to-be-presented-at-esmo-congress-2019/